Fig. 1From: Can clinical and urodynamic parameters predict the occurrence of neutralizing antibodies in therapy failure of intradetrusor onabotulinumtoxin A injections in patients with spinal cord injury?Mean duration of BoNT-A therapy up to the time of NR in NAb+ and Nab patients, p = 0.0153Back to article page